warnings
WARNINGS: Desoximetasone cream USP 0.25% is not for ophthalmic use. Keep out of reach of children.
FDA label 9ab4a65c-290e-4436-b363-2180bdfc142c
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 47ce3a6f-8e5d-46b2-8601-cd5d2339c2a2
- SPL ID
- 9ab4a65c-290e-4436-b363-2180bdfc142c
- Version
- 6
- Effective date
- 2018-12-17
- Source export date
- 2026-10-12
- Source partition
- 7
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/ff22b88bd32e56cbc369af80345075227138a42b1b3ba9a84f038fd5493a7a47/drug-label-0007-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 01:55:11
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 9ab4a65c-290e-4436-b363-2180bdfc142c | id | |
| spl set id | 47ce3a6f-8e5d-46b2-8601-cd5d2339c2a2 | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS: The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Perioral dermatitis Itching Allergic contact dermatitis Irritation Maceration of the skin Dryness Secondary infections Folliculitis Skin atrophy Hypertrichosis Striae Acneiform eruptions Miliaria Hypopigmentation In controlled clinical studies the incidence of adverse reactions was low (0.8%) for desoximetasone cream 0.25% and included burning, folliculitis, and folliculo-pustular lesions.
adverse reactions table
<table width="100%"><col width="47%"/><col width="53%"/><tbody><tr><td styleCode="Toprule " valign="top"><paragraph>Burning </paragraph></td><td styleCode="Toprule " valign="top"><paragraph>Perioral dermatitis </paragraph></td></tr><tr><td valign="top"><paragraph>Itching </paragraph></td><td valign="top"><paragraph>Allergic contact dermatitis </paragraph></td></tr><tr><td valign="top"><paragraph>Irritation </paragraph></td><td valign="top"><paragraph>Maceration of the skin </paragraph></td></tr><tr><td valign="top"><paragraph>Dryness </paragraph></td><td valign="top"><paragraph>Secondary infections </paragraph></td></tr><tr><td valign="top"><paragraph>Folliculitis </paragraph></td><td valign="top"><paragraph>Skin atrophy </paragraph></td></tr><tr><td valign="top"><paragraph>Hypertrichosis </paragraph></td><td valign="top"><paragraph>Striae </paragraph></td></tr><tr><td valign="top"><paragraph>Acneiform eruptions </paragraph></td><td valign="top"><paragraph>Miliaria </paragraph></td></tr><tr><td styleCode="Botrule " valign="top"><paragraph>Hypopigmentation </paragraph></td><td styleCode="Botrule " valign="top"/></tr></tbody></table>
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.